Inflammatory bowel disease: Experimental and clinical: Expression of B7 costimulatory molecules by cells infiltrating the colon in experimental colitis induced by oral dextran sulfate sodium in the mouse

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 11, 2001, Pages 1228-1234

  Grose, Randall H ^a   Howarth, Gordon S ^a,b   Xian, Cory J ^a   Hohmann, Arthur W ^a  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cellular infiltrate; Costimulatory molecules; Experimental colitis; Inflammatory bowel disease; Mice

Indexed keywords

B7 COSTIMULATORY MOLECULE; DEXTRAN SULFATE; LIGAND; PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; WATER; B7 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; COLITIS; COLON; COLON MUCOSA; CONTROLLED STUDY; DISEASE MODEL; ENTERITIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR UPREGULATION; T LYMPHOCYTE; TIME; TREATMENT PLANNING; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CYTOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; COLITIS; COLON; DEXTRAN SULFATE; MALE; MEMBRANE GLYCOPROTEINS; MICE;

EID: 0035523197     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02558.x     Document Type: Article

References (27)

1. Medical therapy in ulcerative colitis
2. Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats
3. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice
4. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7
5. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12
6. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease
7. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease
8. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
9. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
10. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
11. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
12. Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity
13. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function
14. Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: Demonstration of cell-to-cell contact with T lymphocytes
15. Differential distribution of B7.1 (CD80) B7.2 (CD:86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD)
16. A novel method for the induction of reliable experimental acute and chronic ulcerative colitis in mice
17. Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis
18. Distribution of human colonic dendritic cells and macrophages
19. Isolation and characterization of antigen-presenting dendritic cells from the mouse intestinal lamina propria
20. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease
21. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation
22. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation
23. Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis model
24. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion
25. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice
26. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway